RPMB predicts the disease-free survival of head-and-neck squamous carcinoma after adjuvant concurrent radio-chemotherapy.

Front Genet · 2025 · PMC12187736 · PMID 40567901

Europe PMC DOI

hedged sentences

0.2000

closest p · 4.0× alpha

0.3800

boldest claim

The sentences

a clear trendp = 0.2not close (p > 0.1)

Although significance was still not reached, the result revealed a clear trend toward inferior DFS among patients with elevated RPMB levels (HR = 1.585, 95% Cl: 0.781–3.215, p = 0.2, Figure 4C ).

also in 7,418 other papers

did not reach statistical significancep = 0.38not close (p > 0.1)

However, the observed difference in DFS between the two RPMB-assigned groups did not reach statistical significance ( p = 0.38, as depicted in Figure 4A ).

also in 39,124 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.